Cognitive Deficits Seen in COVID-19 Patients Regardless of Symptom Duration
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 29, 2024 -- Similar small cognitive deficits are seen for individuals who recovered from COVID-19 in whom symptoms had resolved in less than four weeks or at least 12 weeks, according to a study published in the Feb. 29 issue of the New England Journal of Medicine.
Adam Hampshire, Ph.D., from Imperial College London, and colleagues estimated a global cognitive score across eight tasks in 112,964 participants who completed an online cognitive assessment.
The researchers found that compared with individuals in the no-COVID-19 group who had not been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or had unconfirmed infection, participants who recovered from COVID-19 in whom symptoms had resolved in less than four weeks or at least 12 weeks had similar small deficits in global cognition (−0.23 and −0.24 standard deviation [SD], respectively), while larger deficits were seen for those with unresolved persistent symptoms (−0.42 SD). Participants who had SARS-CoV-2 infection during periods in which the original virus or the B.1.1.7 variant was predominant had larger deficits than those infected with later variants; deficits were also larger for those who had versus had not been hospitalized. These results were similar to those of propensity score-matched analyses. Memory, reasoning, and executive function tasks were associated with the largest deficit in comparison of the group with unresolved persistent symptoms versus the no-COVID-19 group.
"We found objectively measurable cognitive deficits that may persist for a year or more after COVID-19," the authors write. "The implications of longer-term persistence of cognitive deficits and their clinical relevance remain unclear and warrant ongoing surveillance."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Further Support and Information on COVID-19
Read this next
First Responders With More Debris Exposure Have Higher Risk of Early Dementia
FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.